Feb 3, 2015 · Triptan medications are effective and commonly used to treat migraines in pregnancy
Aug 7, 2023 · The Pregnancy Registry for rizatriptan benzoate tablets did not identify any pattern of congenital anomalies or other adverse birth outcomes over the period of 1998
The Sumatriptan, Naratriptan, and Treximet Pregnancy Registry captured data on women exposed to those drugs during pregnancy to monitor for evidence of major teratogenicity
Jan 21, 2020 · A study using linked data from the Medical Birth Registry of Norway to the Norwegian Prescription Database compared pregnancy outcomes in women who
A few large pregnancy registries covering more than 3,000 pregnancies, have analysed the use of other triptans, (including rizatriptan, zolmitriptan and eletriptan) and found no major congenital defects
The Pregnancy Registry for rizatriptan benzoate did not identify any pattern of congenital anomalies or other adverse birth outcomes over the period of 1998 to 2018
6 Patients with Phenylketonuria
14
Caution advised if rizatriptan is used
The Pregnancy Registry for rizatriptan benzoate did not identify any pattern of congenital anomalies or other adverse birth outcomes over the period of 1998 to 2018
Eur J Epidemiol
However, the lack of identification of any pattern should be viewed with caution, as the number of prospective reports with outcome information was low and did
Drug Class
Pregnancy registries were identified based on several
However, the lack of identification of any pattern should be viewed with caution, as the number of prospective reports with outcome information was low and Call our toll free number 1-866-495-0654 to report any of the following:
evaluates outcomes of the use of rizatriptan during pregnancy through a Pregnancy Registry in the United States (US) and spontaneous reports for pregnancies reported from sources outside the US
The recommended dose of rizatriptan benzoate tablets is 5-mg in patients weighing less than 40 kg (88 lb), and 10 mg in patients weighing 40 kg (88 lb) or more
evaluates outcomes of the use of rizatriptan during pregnancy through a Pregnancy Registry in the United States (US) and spontaneous reports for pregnancies reported from sources